Home > Cashflow Statement > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
Cash Flow from Financing Activities

    Back to Cashflow Statement
COMMUNITY POLL
for GLENMARK PHARMACEUTICALS
Please provide your vote to see the results

GLENMARK PHARMACEUTICALS Last 5 Year Cash Flow from Financing Activities History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Cash Flow from Financing Activities ₹-3,906 Cr₹-77 Cr₹-520 Cr₹-442 Cr₹-445 Cr

What is the latest Cash Flow from Financing Activities ratio of GLENMARK PHARMACEUTICALS ?

The latest Cash Flow from Financing Activities ratio of GLENMARK PHARMACEUTICALS is ₹-3,906 Cr based on Mar2024 Consolidated results.
Year Cash Flow from Financing Activities
Mar2024₹-3,906 Cr
Mar2023₹-77 Cr
Mar2022₹-520 Cr
Mar2021₹-442 Cr
Mar2020₹-445 Cr

How is Cash Flow from Financing Activities of GLENMARK PHARMACEUTICALS Trending?

Years Cash Flow from Financing Activities % Change
Mar2024 ₹-3,906 Cr
Negative
Mar2023 ₹-77 Cr
Negative
Mar2022 ₹-520 Cr
Negative
Mar2021 ₹-442 Cr
Negative
Mar2020 ₹-445 Cr -

Compare Cash Flow from Financing Activities of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹40,810.4 Cr 3.7% 5% 40.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹417,400.0 Cr -0.3% 3.1% 13.4% Stock Analytics
DIVIS LABORATORIES ₹164,844.0 Cr 3.5% 11% 63.5% Stock Analytics
CIPLA ₹121,328.0 Cr 1.6% 2.7% 11.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹110,521.0 Cr 4.1% 4.4% 24.7% Stock Analytics
DR REDDYS LABORATORIES ₹103,043.0 Cr 6.8% 11.3% 3.1% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

3.7%

5%

40.9%

SENSEX

2.7%

11.8%

14%


You may also like the below Video Courses